Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prolotherapy (10% vs 25% Dextrose) for TMJ Anterior Disc Displacement
NCT06859034Phase 3Not yet recruiting
- Sponsor
- Cairo University
- Start
- Mar 2025
- Primary completion
- Sep 2025
01
Overview
Phase 3, randomised trial of dextrose in Anterior disc displacement with reduction (ADDwR) (2 arms), sponsored by Cairo University. Primary endpoint: Change in Pain Severity Measured by Numerical Rating Scale at 6 months. Planned start Mar 2025; status: not yet recruiting.
02
Drugs
dextrose
03
Conditions
Anterior disc displacement with reduction (ADDwR)
Beyond the preview
Go deeper on NCT06859034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06859034.